William Blair & Company’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

William Blair & Company’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-6,704	Closed	-$25K	–	1669
2015 Q2	$25K	Hold	6,704	–	–	﹤0.01%	2167
2015 Q1	$26K	Sell	6,704 -2,125	-24%	-$9.53K	﹤0.01%	2108
2014 Q4	$122K	Sell	8,829 -1,625	-16%	-$23.2K	﹤0.01%	2012
2014 Q3	$129K	Buy	10,454 +1,125	+12%	+$15.5K	﹤0.01%	2006
2014 Q2	$170K	Buy	9,329 +125	+1%	+$2.14K	﹤0.01%	1969
2014 Q1	$199K	Buy	9,204 +2,954	+47%	+$85.6K	﹤0.01%	1906
2013 Q4	$221K	Sell	6,250 -4,875	-44%	-$163K	﹤0.01%	1844
2013 Q3	$402K	Buy	11,125 +8,125	+271%	+$370K	﹤0.01%	1622
2013 Q2	$135K	Buy	+3,000	New	+$136K	﹤0.01%	1862

Other funds holding KBIO

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return

William Blair & Company's KBIO Position: Q3 2015 in Review

William Blair & Company sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q3 2015, closing a stake of 6,704 shares — an estimated $25K sold.

William Blair & Company first reported a position in KBIO in Q2 2013 and held it in 9 quarters. The position peaked at $402K in Q3 2013. 14 funds tracked by Wall St. Rank hold KBIO as of Q3 2015.

William Blair & Company reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q3 2015 after selling out during the quarter.
William Blair & Company sold 6,704 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q3 2015, an estimated $25K.
William Blair & Company first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 9 quarters.
William Blair & Company's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $402K in Q3 2013.
14 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q3 2015.

Based on William Blair & Company's 13F filing for Q3 2015, filed 12 Nov 2015.